Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Will the real multiple sclerosis please stand up?
Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
Diagnosis and treatment of hyponatraemia.
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Parainfectious longitudinally extensive transverse myelitis associated with varicella-zoster virus.
Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Motor skill learning requires active central myelination.
Genentech and Biogen Idec announce top-line results from a Phase II/III clinical trial of Rituxan in primary-progressive multiple sclerosis
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP.
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate.
Pattern of remyelination in the CNS.
[Assessment of the pain patients with the multiple sclerosis after applying the physiotherapy treatment].

Pages